Available: Print -Vol.9NE

By far the world's most definitive & authoritative current ophthalmic drug development volume available.

"No development unit should be without it" - Pliva

We are sorry that this world
leader in ophthalmic R&D
development was not in print 15 years ago for our staff - ALCON

An amazing publication in absolute ophthalmic excellence - Merck Co Inc NY USA

Compulsory reading for our R&D, QA QC RA and formulation/prod units - Bausch & Lomb UK Limited

Thank you for Vol 8, PI+PII absolutely state-of-the art in every shape and form - Merck Sharp & Dohme

Our company purchased the entire 24 vol Handbook Series and we find Vol 8 absolutely outstanding - it contains so much detail - Pliva Pharma

By far the best R&D formulation book in our large library - Allergan Ltd

Your handbook taught us today's ophthalmic sterile technology - Novartis Pharmaceuticals


Money very well spent on your ophthalmic Hand-book, thank you - UCB Pharma Ltd

A truly great publication - and a best seller, a flagship in your series- Pharmacia


LOCUM INT. PRESS
Vol, Edition # and Pub. Year.

H/B Vol 9/Ed 16 - 2016
H/B Vol 9/Ed 17 - 2017
H/B Vol 9/Ed 18 - 2018
H/B Vol 9/Ed 19 - 2019
H/B Vol 9/Ed 20 - 2020
H/B Vol 9/Ed 21 - 2021
H/B Vol 9/Ed 22 - 2022
H/B Vol 9/Ed 23 - 2023
H/B Vol 9/Ed 24 - 2024


New Edition Annually.

Locum Publishers Clients
(Handbooks and Journals.

Handbook Generic Development
Sterile Eye and Nose Preparations
A Two Part Development To Final Production Handbook

Locum International Press

Volume 9NE (Complete Handbook in Two Parts)
of the 24 Volume Drug Development Series.

This lastest two part authoritative Handbook of Pharmaceutical Generic Development is a practical hands-on, technical research and development easily to read and understand reference book packed with all the needed formula, specifications and manufacturing procedures, batch-lot qualification, scale-up stages to full sized batches with all current process specifications and validation protocols and procedures covering the A-Z preparation steps for the creation of profesional CTD/ANDA product sections for the manufacture of Sterile Eye & Nose Preparations (ophthalmic drops, solutions and suspensions and sterile nasal solutions, sprays and drops.)

Extensive coverage of sterile validation protocols from washing machines, steam sterilizers and lyophilizers. Updated current advances and developments in pharmaceutical, formulations, legal and regulatory product development approaches by industry and agency experts that is needed to know and understand for the development of these specialized sterile dosage forms.

Details advanced formula development and sterile process validation, including validation protocols and checklists of all the major sterile cleaning equipment and manufacturing processes, HVAC utilities and appropriate sterilization procedures and equipment

Includes the required pharmaceutical legal and regulatory CTD/e-CTD/ANDA/EU/JAPAN module development know-how providing essential development technology on Sterile Eye & Sterile Nose Preparations for professional top level developers to understand the nuts-and-bolts on Sterile Generic Q1Q2 FDA mandated development in order to produce high-tech detailed CTD/e-CTD/ANDAs. Explains in precise details the FDA/EU inactive ingredient database (FDA-IID) on how to use this formulation database in sterile Eye & Sterile Nose formulations/preparations. Including key Tips and Traps to avoid. Highlights design and formulation concepts using the innovator's RLD via simple reverse-engeneering procedures and challenge tests.

Provides full production formulas and actual manufacturing process documentation for both ophthalmic and nasal drops and solutions of top branded popular commercial products such as Timolol, Naphazoline, Tetrahydrozoline (Visine), Dorzolamide, Zylometazoline nasal drops and Flunisolide nasal solution.

SEAMLESS INTEGRATION
An Essential Reference for Development Pharmacists, R&D Chemists, QA/QC and Regulatory personnel. Each and every document, protocol and procedure in Part I + II is expertly referenced to the appropriate module number in the CTD/e-CTD system thus providing a fully seamless and effortless integration into either US, EU, Japan and Asian application files and dossiers. All IAGIM technology is purposely and uniquely dove-tailed in regulatory drug product applications -worldwide appliations made simple and precise. An extensively comprehensive and authoritative handbook, reference work, formula, process research and development manual of unparallel quality and state-of-the-art technical industrial know-how.

Every document that goes into this CTD/e-CTD / ANDA / EU / JAPAN product development system is explained in detailed, clear precise English with FDA/EU prior-approved document examples on how to structure and layout the key documentation - and what to include and what to omit.

Complete Volume in two parts 1990-2000 pp. Part 1 & 2 fully illustrated and annotated with diagrams, flow charts, formula, graphs, spectra, side-by-side comparisons, tables in b/w & color. Available in print (spiral soft cover opens flat) or via digital CD (multi-users require additinal optional license). Split volume attract a 25% handling and broken volume charge to split the two part volume.


About Us
Locum International Pharma Press are one of the world leading scientific R&D technical publishers offering an exceptional range of peer reviewed journals, handbooks, book databases and publishing services to the pharmaceutical science community. We also offer a large and comprehensive range of product specific generic handbooks to the pharmaceitical generic drug and innovative drug R&D community

ISSN: 0793 7601 / 0793-761X

Price Go to: Locum International Catalog

 



 

| Ready-To-Go Link | Handbook Series | Journal Index | Specialized Journals |